| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 2.713 | 17.902 | 26.701 | 25.437 | 23.079 | 26.261 | 40.014 | 54.968 | 55.274 |
| Total Income - EUR | - | 2.713 | 17.902 | 26.701 | 25.437 | 23.079 | 26.261 | 40.014 | 54.968 | 55.274 |
| Total Expenses - EUR | - | 475 | 1.392 | 6.696 | 8.513 | 7.068 | 4.861 | 2.230 | 11.802 | 29.439 |
| Gross Profit/Loss - EUR | - | 2.238 | 16.510 | 20.005 | 16.924 | 16.011 | 21.400 | 37.784 | 43.166 | 25.835 |
| Net Profit/Loss - EUR | - | 2.156 | 15.973 | 19.738 | 16.669 | 15.780 | 20.689 | 36.823 | 42.726 | 24.177 |
| Employees | - | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 |
Check the financial reports for the company - Alergologie Dr Urse Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 791 | 1.270 | 654 | 105 | 0 | 0 | 24.309 | 18.001 |
| Current Assets | - | 2.449 | 15.990 | 34.960 | 51.918 | 68.677 | 20.830 | 37.744 | 26.377 | 11.788 |
| Inventories | - | 0 | 0 | 0 | 0 | 857 | 0 | 0 | 0 | 0 |
| Receivables | - | 663 | 7.549 | 7.498 | 10.421 | 0 | 0 | 36.823 | 17.681 | 0 |
| Cash | - | 1.786 | 8.441 | 27.462 | 41.498 | 67.820 | 20.830 | 921 | 8.696 | 11.788 |
| Shareholders Funds | - | 2.201 | 16.166 | 35.607 | 51.587 | 66.389 | 20.738 | 36.872 | 42.774 | 24.225 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 248 | 615 | 623 | 986 | 2.393 | 92 | 872 | 7.911 | 5.564 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Alergologie Dr Urse Srl